000 01273 a2200361 4500
005 20250513095246.0
264 0 _c19961022
008 199610s 0 0 ita d
022 _a0009-9074
040 _aNLM
_beng
_cNLM
100 1 _aZennaro, R
245 0 0 _a[Normalization of the prolactin values during alfa-interferon therapy: the considerations with a female patient with anti-HCV-positive chronic hepatitis and prolactin-secreting hypophyseal microadenoma].
_h[electronic resource]
260 _bLa Clinica terapeutica
_cApr 1996
300 _a169-71 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdenoma
_xblood
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHepatitis C
_xblood
650 0 4 _aHepatitis, Chronic
_xblood
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aPituitary Neoplasms
_xblood
650 0 4 _aProlactin
_xblood
650 0 4 _aRecombinant Proteins
650 0 4 _aTime Factors
700 1 _aPetracca, E G
700 1 _aPaolini, R
700 1 _aRamazzina, E
773 0 _tLa Clinica terapeutica
_gvol. 147
_gno. 4
_gp. 169-71
999 _c8763168
_d8763168